WHO Drug Information Vol. 20, No. 4, 2006 - World Health ...

WHO Drug Information, Vol. 20, No. 4, 2006 Proposed INN: List 96
C31H43N3O8
H 2C
O
N
H
O
NH
CH 3
H
H 3CO
H3C O HO H
H H H
CH3 OCH3 CH3 75747-14-7
O NH 2
telatinibum
telatinib 4-[({4-[(4-chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl}oxy)methyl]-
N-methylpyridine-2-carboxamide
antineoplastic
télatinib 4-[({4-[(4-chlorophényl)amino]furo[2,3-d]pyridazin-7-yl}oxy)méthyl]-
N-méthylpyridine-2-carboxamide
antinéoplasique
telatinib 4-[({4-[(4-clorofenil)amino]furo[2,3-d]piridazin-7-il}oxi)metil]-
N-metilpiridina-2-carboxamida
antineoplásico
C20H16ClN5O3
H 3C
N
H
O
N
O
O N N
tesamorelinum
tesamorelin (3E)-hex-3-enoylsomatoliberin (human GHRH)
growth hormone release-stimulating peptides
H
N
H
O
332012-40-5
tésamoréline (3E)-hex-3-enoylsomatolibérine humaine
peptide stimulant la libération de l'hormone de croissance
tesamorelina (3E)-hex-3-enoilsomatoliberina humana
péptido estimulante de la liberación de la hormona del crecimiento
C221H366N72O67S
O
H 3C
Cl
218949-48-5
Tyr Ala Asp Ala Ile Phe Thr Asn Ser Tyr
10
Arg Lys
Val Leu Gly Gln Leu Ser Ala Arg
20
Lys Leu Leu Gln
Asp Ile Met Ser Arg Gln
30
Gln Gly Glu Ser Asn Gln
Glu Arg Gly Ala
40
Arg Ala Arg Leu NH2 297